Noteworthy - October 2022

TEDxPortland features Erin Tran and his work in cancer immunotherapy
Providence Cancer Institute’s Eric Tran, Ph.D., and his team are pioneering breakthroughs in cancer immunotherapy, using adoptive cell therapy. Dr. Tran recently addressed the popular TEDxPortland conference and talked about how this innovative work targets cancerous cells and removes them from the body. Watch his presentation here.

Providence lung cancer experts to speak at Portland science summit
On Nov. 17, OncLive in partnership with Providence Cancer Institute of Oregon, will host “State of Science Summit: Lung Cancer.” OncLive is a leading digital provider of resources and information to oncology professionals.

This in-person summit will cover new cancer treatment approaches, research and strategies. Featured speakers include Providence oncology experts Rachel Sanborn, M.D., Evelyn Brosnan, M.D., Regan M. Duffy, M.D., MPH, and Michael D. Skokan, M.D. Dr. Sanborn, medical director, Providence Thoracic Oncology Program, will chair the event. Registration is free. Learn more here.  

Intermediate care facility opening at Providence Portland Medical Center
The first floor of the Center for Medically Fragile Children at Providence Child Center is being converted into a 28-bed intermediate care facility. The ICF, which is scheduled to open mid-2023, will serve patients who no longer need hospital care and are not ready to return home or to their residential care facility. This will open capacity to allow our hospitals to care for patients who need a higher level of care.

Located on the Providence Portland Medical Center campus, the Center for Medically Fragile Children has experienced a declining census in recent years and no longer needs as many beds. The CMFC residents will be relocated to the second floor, which gives them easy access to their rooftop outdoor garden, therapy spa room, indoor pool and family apartment.

New hypertrophic cardiomyopathy program to help save lives
Providence Heart Institute has launched the David Heller Center for Hypertrophic Cardiomyopathy, named in honor of 17-year-old David Heller of Portland who died in 2005 of the disease in his sleep. Afterward, his family established the David Heller Foundation that has funded youth heart screenings and donated hundreds of AEDs to schools. The foundation recently made a $500,000 gift to establish the center at Providence Heart Institute, which includes supporting the Play Smart heart screenings for youth.

$500K Gift Given to Providence Hypertrophic Cardiomyopathy Program
Play Smart: What you need to know about our youth heart screenings

Providence Cancer Institute welcomes new providers 

  • Providence Gynecologic Oncology Program 
    Neda Jooya, M.D., gynecologic oncology, Franz and West clinics 
  • Providence Breast Surgery Clinic - West  
    Allison C. Nauta, M.D., plastic and reconstructive surgery 
  • Providence Cancer Institute Franz Thoracic Surgery 
    David Chen, M.D., thoracic surgery, research 

New season of Heart to Start starts in November
Providence Heart Institute’s 11th season of the popular Heart to Start program begins next month, and registration is now open. The fitness program encourages participants to take several small steps and work together as a group toward better health. Training for a 5K is the foundation of the program, which welcomes walkers and runners of all paces and experience. To learn more and to register, click here.

About the Author

The inScope content team focuses on bringing you the latest in clinical news from our team of world-class medical providers and physician leaders.

More Content by Providence inScope Content Team
Previous Article
Providence Medford emergency department earns geriatric accreditation
Providence Medford emergency department earns geriatric accreditation

As the baby boomer generation gets older, hospitals and clinics are seeing more geriatric patients.

Next Article
Providence Cancer Institute in unique position to evolve TCR gene therapy
Providence Cancer Institute in unique position to evolve TCR gene therapy

Providence Cancer Institute of Oregon is one of only two academic facilities in the U.S. that currently has...